Phaarmasia Ltd (PHRMASI) is currently trading at 89.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Phaarmasia Limited is a Hyderabad-based pharmaceutical manufacturer focused on hormonal oral contraceptive tablets and combipacks with iron tablets, operating a WHO-GMP and ISO 9001 certified facility with stated manufacturing capacity exceeding 30 million units per annum and two listed units at Jeedimetla industrial area. The company reported consolidated revenue from operations of Rs. 828.33 lakhs for the quarter ended 30 June 2026, up sequentially from Rs. 773.19 lakhs and up year-on-year from Rs. 687.36 lakhs, indicating improving top-line momentum within its single reporting segment during the quarter. Profit after exceptional items for the quarter is reported as Rs. 30.44 lakhs with a basic and diluted EPS of Rs. 0.50, yielding an approximate quarterly PAT margin of 3.7 percent; the prior quarter showed a loss before exceptional items, so the quarter reflects operational recovery at modest margins. Corporate disclosures are formal and conservative: the board approved the quarterly results, the statutory auditors issued a limited review with no adverse qualifications, and the CFO provided the mandatory certificate under regulation; there is no concall transcript or detailed management guidance in the provided investor materials.

Over the past 52 weeks, Phaarmasia Ltd has traded between a low of ₹30.32 and a high of ₹131.75. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Phaarmasia Ltd has a market capitalization of approximately 62.35. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Phaarmasia Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 3.53 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 62.35 Cr, Phaarmasia Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Phaarmasia Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Phaarmasia Ltd is 3.53. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.